Neuromodulation
Vagus nerve stimulation, or VNS, is an implanted neuromodulation treatment used for some people with drug-resistant epilepsy. It is generally intended to reduce seizure burden rather than guarantee seizure freedom.
Central point: VNS is an add-on treatment. It does not replace antiseizure medication automatically, and not everyone responds to it.
When is VNS considered?
NICE recommends considering VNS as an add-on treatment to antiseizure medication when a person has drug-resistant seizures and resective epilepsy surgery is not suitable. The decision should follow discussion of expected benefits, limitations and risks.
How does the device work?
A small pulse generator is implanted under the skin of the chest and connected by a lead to the left vagus nerve in the neck. The device sends programmed electrical impulses at intervals. The exact mechanisms by which VNS reduces seizures are not fully understood, but stimulation is thought to influence distributed brain networks involved in seizure generation and propagation.
What happens after implantation?
The stimulator is usually activated and adjusted gradually after surgery. Settings can be changed during follow-up appointments according to seizure response and adverse effects. Improvement may develop over time rather than immediately.
What is the magnet for?
Many VNS systems allow a magnet to be passed over the generator to deliver an extra burst of stimulation. Some people use this when they recognise the start of a seizure, while carers may use it when they see a seizure beginning. It is not a guaranteed way to stop a seizure and it should not replace an emergency or rescue-medication plan.
How effective is VNS?
Response varies. Clinical trials and long-term observational studies show that many people experience meaningful seizure reduction, while some have little benefit and a smaller proportion become seizure-free. The effect can improve over months or years in some people. Because study populations and definitions differ, a single response percentage should not be treated as a promise for an individual.
Common adverse effects
Stimulation-related effects can include hoarseness or voice change, throat discomfort, coughing, shortness of breath or a tingling sensation during stimulation. Surgical risks include infection, bleeding, pain and damage to nearby structures. Battery replacement requires another procedure when the generator reaches end of service.
Sleep and breathing considerations
VNS can affect breathing during sleep in some people and may worsen sleep-disordered breathing. Symptoms such as loud snoring, witnessed apnoeas, marked daytime sleepiness or new nocturnal breathing problems should be discussed with the epilepsy team because device settings and sleep assessment may need review.
MRI and VNS
Modern VNS systems may be MRI-conditional rather than simply MRI-safe or MRI-unsafe. Whether MRI can be performed depends on the exact implanted model, body area and scanner conditions. The radiology team must know that a VNS device is present and follow the manufacturer’s conditions for that specific system.
Does VNS cure epilepsy?
No. VNS is best understood as a palliative neuromodulation treatment intended to reduce seizure frequency or severity and sometimes improve recovery or quality of life. Some people have very large improvements, but it should not be described as a cure.
Related pages
Drug-Resistant Epilepsy · Epilepsy Surgery and Presurgical Assessment · DBS, RNS and Other Neurostimulation · Treatment Options
What VNS can and cannot do
Vagus nerve stimulation is a palliative neuromodulation treatment for drug-resistant epilepsy. It does not remove an epileptogenic zone and usually does not produce immediate seizure freedom. Benefit often builds over months or years, and response is commonly measured as reduction in seizure frequency or severity rather than cure.
How it works
A pulse generator in the chest delivers intermittent electrical stimulation through an electrode wrapped around the left vagus nerve in the neck. Modern systems may also deliver extra stimulation when rapid heart-rate change suggests a seizure, although this feature is not equally useful for every seizure type.
Who may be considered
VNS is often considered when seizures remain drug resistant and resective or ablative surgery is unsuitable, declined or unlikely to remove the whole epileptogenic network. It can also be used alongside other treatments rather than as a final option.
Adverse effects
Common stimulation-related effects include hoarseness, cough, throat discomfort, voice change and shortness of breath during stimulation. Surgical complications such as infection are less common. Sleep-disordered breathing can worsen in some people and should be considered when symptoms suggest it.
Expectations and follow-up
Programming is adjusted gradually. Lack of early response does not always predict long-term failure, but continued treatment should still be reviewed against seizure burden, side effects, battery life and individual goals.
Sources
NICE NG217 — Non-pharmacological treatments
ILAE Surgical Therapies Commission — neurostimulation evidence
This page provides general educational information and is not individual medical advice.
Evidence checked: September 2026.